Relmada Therapeutics, Inc. (RLMD) — DEF 14A Filings
All DEF 14A filings from Relmada Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Relmada Therapeutics Files Proxy Statement
— Apr 11, 2025 Risk: low
Relmada Therapeutics, Inc. filed its definitive proxy statement on April 11, 2025, for its annual meeting on May 23, 2025. The company, formerly known as Camp N -
Relmada Therapeutics Revises and Relaunches Pivotal Phase 3 Program for REL-1017
— Apr 9, 2024 Risk:
RELMADA THERAPEUTICS, INC. (RLMD) filed a Proxy Statement (DEF 14A) with the SEC on April 9, 2024. Relmada Therapeutics revised and relaunched its pivotal Phase
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX